05/20/2026
People keep acting like platforms like GoodRx, Cost Plus Drugs and the new TrumpRX-style discount programs are some kind of revolution against Big Pharma.
Reality check: most of these “discount” systems are still operating inside the exact same PBM-controlled ecosystem that created the pricing mess in the first place.
The average person thinks:
“Wow, I beat the system. My prescription went from $200 to $28!”
But what they don’t realize is the ORIGINAL inflated price was often artificially manipulated to begin with. The discount card looks like a hero because the system made the price absurd first.
PBMs (Pharmacy Benefit Managers) sit in the middle of roughly 80% of the prescription market. They negotiate prices, rebates, formularies, pharmacy networks, and reimbursement rates. Many are owned by massive insurance companies whose legal responsibility is maximizing shareholder value, not lowering your healthcare costs.
So what happens?
A drug gets marked up.
A “discount” gets applied.
Consumers feel like they won.
Insurance companies and PBMs still collect their cut.
That’s why you’ll sometimes see a cash price cheaper than insurance…which should make absolutely no sense in a functioning market.
And before someone says “but Mark Cuban or President Trump lowered prices” ... yes, some transparency and cost-plus pricing pressure is a GOOD thing. It exposes how ridiculous the pricing structure has become. But even those systems still rely heavily on the same wholesalers, pharmacy infrastructure, and PBM-driven pricing environment dominating the market.
This isn’t a free market success story.
It’s a middleman empire.
The illusion is that Americans are getting discounts.
The reality is many are simply being charged less than the artificially inflated number they were never supposed to pay in the first place.
